Effectiveness Of Homoeopathic Medicines In Increasing Haemoglobin Level In Pregnant Anaemic Women

Background:Anaemia is prevalent in society as leading disorder is for dissertationwhich starts usually since birth and it is seen at any age during life time irrespective of sex, area, community or life style. It seems to be difficult to treat or prevent the occurrences by the government because it is multi facet illness, in the sense that there are several types of anaemia and with different causative factors, the line of treatment varies with each and every group of patient with same causative factor or similar symptoms totality. Aim:To evaluate the efficacy of Homoeopathic medicines and Homoeopathic Approach in Increasing Haemoglobin Level in Pregnant Anaemic Women. Material And Methods:Number of cases:60, Duration of study: 24 months. Result:Laboratory Findings: Haemoglobin levels before and after the treatment, Case record form is especially modified to take the historyof Anaemia, Inclusion criteria: Only pregnant anaemic women of child bearing age are included in the study.Conclusion:As per the totality of case the most similar remedy were chosen to satisfy Susceptibility. And the Indicated Constitutional Dynamic Medicine was administered to establish a state of Health and in few cases, Biochemic Medicines were also been prescribed, depending on the deficiency of concerned salts.

Understand The Role Of Susceptibility In Acute Disease

Day in and dayout we come across acute diseases in our practice. It is observed in clinic practice of almost all physicians that majority of the cases are of acute origin and the rest are chronic in nature. Usually acute disease presents to us with distinct characteristic form which suggest acute remedy. In order to treat as early as possible acute cases becomes the prime need of the physician. We have noted that an organism is constantly required to adapt itself to its environmental conditions so that harmony is maintained. This process of adaptation can take lace on account of the susceptibility. To undertake such study we need to examine acute diseases. We need to understand the role of susceptibility and miasm in every case. In developing countries like India, infectious diseases are the commonest cause of mortality. Especially diseases like Typhoid fever, Acute Viral Hepatitis and Pneumonia are very frequent cause of admission and also a frequent enemy to encounter in O.P.D.

Dentigerous cyst associated with impacted permanent maxillary canine.

Odontogenic developmental cysts of jaws usually presents as asymptomatic lesions. Dentigerous cyst is one of the variety of these cysts which may grow to a large size intraosseously within jaws before it manifest clinically. Numerous immunohistochemical and molecular marker studies have been carried out for this lesion to understand its etiopathogenesis and aggressive behavior. Another reason being its potential to transform to ameloblastoma and squamous cell carcinoma. We present a case of dentigerous cyst associated with impacted maxillary canine manifesting as a unilateral swelling of midface region.

Picrorhiza kurroa (Kutaki) Royle ex Benth as a hepatoprotective agent--experimental & clinical studies.

Picrorhiza kurroa (Pk), a known hepatoprotective plant, was studied in experimental and clinical situtations. The standardization of active principles--Picroside 1 and 2 was done with High Performance Liquid Chromatography. Picroside 1 ranged from 2.72 to 2.88 mg/capsule and picroside 2 from 5.50 to 6.00 mg/capsule. In the galactosamine-induced liver injury in rats, Pk at a dose of 200 mg/kg p.o. showed a significant reduction (p < 0.05) in liver lipid content, GOT and GPT. In a randomised, double-blind placebo controlled trial in patients diagnosed to have acute viral hepatitis (HBsAg negative), Pk root powder 375 mg three times a day was given for 2 weeks (n = 15) or a matching placebo (n = 18) was given. Difference in values of bilirubin, SGOT and SGPT was significant between placebo and Pk groups. The time in days required for total serum bilirubin to drop to average value of 2.5 mg% was 75.9 days in placebo as against 27.44 days in Pk group. The present study has shown a biological plausability of efficacy of Pk as supported by clinical trial in viral hepatitis, hepatoprotection in animal model and an approach for standardizing extracts based on picroside content.

A two-stage clinical trial of Phyllanthus amarus in hepatitis B carriers: failure to eradicate the surface antigen.

BACKGROUND: There have been conflicting data in literature about the value of Phyllanthus amarus in treating hepatitis B virus-related disorders. AIM: To evaluate the role of Phyllanthus amarus in eradication of the virus in hepatitis B carriers. METHODS: Phyllanthus amarus was administered to 30 asymptomatic carriers of hepatitis B surface antigen (HBsAg) in a dosage of 250 to 500 mg thrice daily for 4 to 8 weeks. RESULTS: None of the 30 subjects cleared HBsAg. Phyllanthus amarus was well tolerated, with no clinical side effects or changes in the organ profiles for safety evaluation. CONCLUSION: Phyllanthus amarus is not effective in clearing HBsAg in asymptomatic carriers of the antigen.